Prognosis performance comparison. The performance (time-AUC; A and C) and accuracy (Brier score; B and D) for death prediction were measured over the time for usual prognosis scoring systems, the 4-tier genomic classification (NGS) alone, or in combination for primary (A-B) and secondary (C-D) myelofibrosis patients.